Haemophilia: open trials in Italy

23 open trials have a site in Italy. Registry data; only the trial team decides who can take part.

NCT05987449
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Trial Treatment · Phase 1/2 · Hoffmann-La Roche
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Humanitas Research Hospital, Rozzano
Registry updated 2026-11-05
NCT07416604
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Azienda Ospedaliero-Universitaria Careggi, Florence · Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Azienda Ospedaliera Universitaria Federico II Di Napoli, Naples · Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-11-03
NCT07830732
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Trial Treatment · Phase 3 · Novo Nordisk A/S
Azienda Ospedaliero-Universitaria Careggi, Florence · Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Azienda Ospedaliera Universitaria Federico II Di Napoli, Naples · Azienda Ospedaliera di Padova, Padova
Registry updated 2026-10-28
NCT07285460
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Trial Treatment · Phase 3 · Sanofi
Azienda Ospedaliero-Universitaria Careggi, Florence · Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Azienda Ospedaliera di Padova, Padova · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-10-27
NCT05145127
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Trial Treatment · Phase 3 · Pfizer
IRCCS Istituto Giannina Gaslini, Genoa · Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Azienda Ospedaliero Universitaria Parma, Parma · Azienda Ospealiero Universitaria Policlinico Umberto I, Rome · Ospedale Pediatrico Bambino Gesù, Rome · Humanitas Mirasole S.p.A., Rozzano · Azienda Ospedaliera Universitaria Citta Della Salute E Della Scienza Di Torino, Turin
Registry updated 2026-10-26
NCT07088458
An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-10-26
NCT07416526
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Azienda Ospedaliero-Universitaria Careggi, Florence · Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Azienda Ospedaliera Universitaria Federico II Di Napoli, Naples · Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-10-26
2025-523660-21-00
A Non-Investigational Product, Multi-Center Cohort Study to Describe Long-Term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec
Trial Treatment · Phase 3 · Pfizer Inc.
Azienda Ospedaliera Universitaria Federico II, Napoli
Registry updated 2026-10-23
NCT06379789
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Careggi University Hospital, Florence · IRCCS Istituto Giannina Gaslini, Genoa · Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Ospedale Pediatrico Bambino Gesù, Rome · Humanitas Mirasole S.p.A., Rozzano · Azienda Unita Locale Socio Sanitaria N 8 Berica, Vicenza
Registry updated 2026-10-21
NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Trial Treatment · Phase 3 · Pfizer
Giannina Gaslini Institute For Scientific Hospitalization And Care, Genoa · Azienda Ospedaliero Universitaria Parma, Parma · Bambino Gesu Childrens Hospital, Rome · Humanitas Research Hospital, Rozzano · Azienda Ospedaliero Universitaria Citta Della Salute E Della Scienza Di Torino, Turin
Registry updated 2026-10-14
NCT07867821
Identification of New Biomarkers in Haemophilic Arthropathy Through Transcriptome Analysis
Trial Treatment · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan
Registry updated 2026-10-09
NCT07867834
Tight Control of Treatment Adherence and Efficacy by Telemedicine for an Improved Personalized Management of Patients With Hemophilia
Trial Treatment · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan
Registry updated 2026-10-09
NCT06145373
A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Trial Treatment · Phase 4 · Sanofi
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan · Humanitas Research Hospital, Rozzano
Registry updated 2026-09-23
2024-511814-20-00
A Phase Ib Safety, Pharmacokinetics and Pharmacodynamics Study of TU7710 in Patients with Haemophilia A or B
Trial Treatment · Phase 1 · Tiumbio Co. Ltd.
Careggi University Hospital, Florence
Registry updated 2026-09-18
NCT07220564
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Trial Treatment · Phase 1 · Novo Nordisk A/S
Azienda Ospedaliero-Universitaria Careggi, Florence · Azienda Ospedaliera Universitaria Federico II Di Napoli, Naples
Registry updated 2026-09-18
2022-502061-17-00
Nuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
Trial Treatment · Phase 4 · Octapharma AG
Azienda Ospedaliera Pugliese Ciaccio, Catanzaro · Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone, Palermo · Azienda Sanitaria Universitaria Integrata Del Trentino, Trento
Registry updated 2026-07-10
NCT03695978
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Research · Octapharma
Ospedale Pediatrico "Giovani XXIII", Bari · Policlinico Sant'Orsola-Malpighi, Bologna · Ospedale San Giacomo, Castelfranco Veneto · Azienda Ospedaliera-Universitaria Policlinico "Vittorio Emanuele", Centro di Riferimento Regionale per la Prevenzione, Diagnosi e Cura delle Malattie Rare della Coagulazione nel Bambino e neel'Adulto. U.O.C Ematologia con trapianto di Midollo Osseo, Catania · Azienda Ospedaliero-Universitaria Careggi, Florence · Center for Thrombosis and Hemorrhagic Diseases, IRCCS Humanitas Research Hospital, Milan · Ospedale Maggiore Policlinico, Milan · Centro Emofilia - AUO di Padova, Padova · Policlinico Umberto I, Rome · C.tro Emofilia A.O. Città della salute e della scienza di Torino, Ospedale Regina Margherita, Torino · Ospedale Regina Margherita, Turin
Registry updated 2026-06-02
NCT05935358
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Trial Treatment · Phase 4 · Octapharma
Azienda Ospedaliera Pugliese Ciaccio, Catanzaro · Azienda Ospedaliero Universitaria Careggi - Centro Emofilia, Florence · Centro Trombosi e Malattie Emorragiche, ITCCS Humanitas Research Hospital, Milan
Registry updated 2026-05-12
NCT05936580
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Trial Treatment · Phase 4 · Octapharma
Aziendo Ospedaliera "Puglieze Ciaccio", Catanzaro · Policlinico "P. Giaconne", Palermo
Registry updated 2026-05-12
NCT05768386
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
Research · Phase 4 · BioMarin Pharmaceutical
Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan
Registry updated 2026-01-12
NCT04574076
A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®
Research · Novo Nordisk A/S
Azienda Ospedaliera-Universitaria Parma, Parma · Policlinico Umberto I Sezione Ematologia, Roma · A.O.U Città Salute Scienza Torino, Torino · Ospedale San Bortolo, Vicenza
Registry updated 2025-12-22
2022-502060-21-00
Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
Trial Treatment · Phase 4 · Octapharma AG
Azienda Ospedaliera Pugliese Ciaccio, Catanzaro · Careggi University Hospital, Florence · Humanitas Research Hospital, Rozzano
Registry updated 2025-09-25
NCT02979119
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Research · PedNet Haemophilia Research Foundation
Azienda Ospedaliero-Universitaria Careggi, Florence · Gaslini Hospital, Genova · A. Bianchi Bonomi Hemophilia and Thrombosis Centre IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan
Registry updated 2025-09-16

All Haemophilia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error